These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 17608760

  • 1. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
    Lee Y, Seo YJ, Lee JH, Park JK.
    Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
    [Abstract] [Full Text] [Related]

  • 2. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A, Kanwar AJ, Parsad D, De D.
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [Abstract] [Full Text] [Related]

  • 3. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W, Nieuweboer-Krobotova L.
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [Abstract] [Full Text] [Related]

  • 4. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D, Kanwar AJ, Kumar B.
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [Abstract] [Full Text] [Related]

  • 5. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TM, Hawk JL.
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [Abstract] [Full Text] [Related]

  • 6. Calcipotriol and PUVA as treatment for vitiligo.
    Cherif F, Azaiz MI, Ben Hamida A, Ben O, Dhari A.
    Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
    [Abstract] [Full Text] [Related]

  • 7. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.
    Yalçin B, Sahin S, Bükülmez G, Karaduman A, Atakan N, Akan T, Kölemen F.
    J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538
    [Abstract] [Full Text] [Related]

  • 8. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A, Lurz C, Hamm H, Bröcker EB, Hofmann UB.
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [Abstract] [Full Text] [Related]

  • 9. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS, Lan CC, Wang LF, Chen GS, Wu CS, Yu HS.
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
    Radmanesh M, Saedi K.
    J Dermatolog Treat; 2006 Jan; 17(3):151-3. PubMed ID: 16854754
    [Abstract] [Full Text] [Related]

  • 11. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D, Cassano N, Vena GA.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [Abstract] [Full Text] [Related]

  • 12. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E, Taştan HB, Erbil AH, Sezer E, Koç E, Kurumlu Z.
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [Abstract] [Full Text] [Related]

  • 13. Photo(chemo)therapy for vitiligo.
    Pacifico A, Leone G.
    Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
    [Abstract] [Full Text] [Related]

  • 14. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TT, Hawk JL.
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [Abstract] [Full Text] [Related]

  • 15. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB, Hann SK, Bystryn JC.
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [Abstract] [Full Text] [Related]

  • 16. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
    Bhatnagar A, Kanwar AJ, Parsad D, De D.
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
    [Abstract] [Full Text] [Related]

  • 17. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P, Iuga A, Dacko A, Hardick K.
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [Abstract] [Full Text] [Related]

  • 18. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU, Krüger C, Würfel BA, Panske A, Wood JM.
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema.
    Adişen E, Karaca F, Oztaş M, Gürer MA.
    Clin Exp Dermatol; 2008 May; 33(3):344-5. PubMed ID: 18093241
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O, Herz-Ruelas ME, Gómez M, Ocampo-Candiani J.
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.